Story

How Effective is That Dog Drug Off the Shelf?

Simulations Plus to test veterinary medicines for the FDA.

Simulations Plus to test veterinary medicines for the FDA.

Story

โ€˜Advancedโ€™ AI Firm Moving into Health Care

MEDICAL: Glendale firm appoints business development chief.

Glendale artificial intelligence company expands into health technology.

Story

Amgen Seeks New Monthly Dosage for Repatha

Amgen Inc. has submitted an application for regulatory approval of a new single-dose syringe for cholesterol drug Repatha, the company announced Friday.

Story

Amgen Adds Warning About Higher Doses of Anemia Drugs

Studies on similar drugs show that off label dosages can put patients at risk.

Story

Afrezza for Sale in U.S.

MannKind Corp. announced on Tuesday that its Afrezza brand of inhalable insulin is now available by prescription at U.S. pharmacies.

Story

MannKind Moves Higher on Afrezza Label Update

MannKind Corp. today announced that the U.S. Food & Drug Administration has updated prescribing information for Afrezza, the companyโ€™s sole commercial product.

Story

New Scanning System Increases Patient Safety

Panorama City Hospital has started using medication bar code scanning, the first Southern California hospital in the Kaiser Permanente system to do so.

Story

Glendale Donors Fund State-of-the Art CT Scanner

Thanks to donors, Glendale Adventist Medical Center was able to purchase a new premier CT scanner that will make for faster diagnosis.

Story

Momentum Pushes MannKind Up 25 Percent

Riding the momentum of last weekโ€™s gains, MannKind Corp. closed up again more than 25 percent Tuesday.

Story

Amgen

Faced with slowing sales of its two primary products, Amgen Inc., the Thousand Oaks-based biotech company, has intensified its search for super-profitable drugs.

Story

Medtronic Launches Smart Insulin Pen Device

Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.

Story

Amgen Looks at Additional $1 Billion In Annual Sales With Drugโ€™s Approval

BIOTECH: Bright future seen for Thousand Oaks firm after flat years.

Amgen expected to see big increase in revenue when it enters new oncology market with drug XGEVA following approval by U.S. FDA.

Story

Simulations Plus Upgrades Drug Software

Simulations Plus Inc. on Wednesday announced the release of the latest version of its main software product GastroPlus.

Story

MannKind Gains Another 20 Percent on New FDA Label

Following a 7 percent increase Monday, shares of MannKind Corp. stayed bullish, closing up more than 20 percent increase on Tuesday.

Story

Dog Drug Theory

Immix Biopharma founder Ilya Rachman thinks he has a new way to develop medicines, and his first proof is a now-healthy canine patient.

Doctor cures cancer in dog, looks to humans next.

Story

Can Timer Cap Put a Lid on Opioid Epidemic?

SAFETY: Moorpark firm finds abuse prevention market for a convenience product.

Timer Cap isnโ€™t trying to solve the opioid epidemic. But it does think it can help when it comes to prevention.

Story

FDA Approves Label Expansion for Amgen's Repatha

The Food and Drug Administration has approved Amgen Inc.โ€™s drug Repatha as a prevention for heart attacks in patients with cardiovascular disease, potentially enlarging the customer base for the drug.

Story

Simulations Plus Collaboration to Research Joint Medications

Simulations Plus has partnered with an unnamed clinical-stage biotech company to develop a new delivery model using its GastroPlus software.

Story

FDA Approves Amgen Cholesterol Drug Repatha

Amgen Inc. has received approval to market its cholesterol drug Repatha in the United States.

Story

U.S. HealthWorks Wins Contract from Two Central Valley Employers

U.S. HealthWorks of Valencia was chosen to operate two on-site health centers for Foster Farms, a leading, family-owned poultry producer, in the Central Valley towns of Turlock and Livingston.

Previous